Tech Company Financing Transactions

Proclara Biosciences Funding Round

Proclara Biosciences closed a $10 million Series D financing round on 1/14/2015. Investors included private investors.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series D
Proceeds Purpose
Proceeds from the financing will be used to advance the Company's lead drug candidate, NPT088, into clinical studies by the end of this year.

Company Information

Company Status
Private & Independent
Mailing Address
125 Cambridgepark Dr. 301
Cambridge, MA 02140
Email Address
Not Recorded
Proclara Biosciences is a biotechnology company advancing product candidates developed based on proprietary GAIM technology, which is capable of simultaneously targeting multiple toxic misfolded proteins.
Proclara Biosciences LinkedIn Company Profile
Social Media
Proclara Biosciences Company Twitter Account
Company News
Proclara Biosciences News
Proclara Biosciences on Facebook
Proclara Biosciences on YouTube

Management Team

Email & Social
Chief Executive Officer
Suzanne Bruhn
  Suzanne Bruhn LinkedIn Profile  Suzanne Bruhn Twitter Account  Suzanne Bruhn News  Suzanne Bruhn on Facebook
Chief Medical Officer
David Michelson
  David Michelson LinkedIn Profile  David Michelson Twitter Account  David Michelson News  David Michelson on Facebook
Chief Scientific Officer
Richard Fisher
  Richard Fisher LinkedIn Profile  Richard Fisher Twitter Account  Richard Fisher News  Richard Fisher on Facebook
VP - Manufacturing
Jason Wright
  Jason Wright LinkedIn Profile  Jason Wright Twitter Account  Jason Wright News  Jason Wright on Facebook
VP - Operations
Kelly Magnuson
  Kelly Magnuson LinkedIn Profile  Kelly Magnuson Twitter Account  Kelly Magnuson News  Kelly Magnuson on Facebook
VP - R & D
Rajaraman Krishnan
  Rajaraman Krishnan LinkedIn Profile  Rajaraman Krishnan Twitter Account  Rajaraman Krishnan News  Rajaraman Krishnan on Facebook
VP - R & D
Jonathan Levenson
  Jonathan Levenson LinkedIn Profile  Jonathan Levenson Twitter Account  Jonathan Levenson News  Jonathan Levenson on Facebook
VP - Regulatory Affairs
Roxanne Bales
  Roxanne Bales LinkedIn Profile  Roxanne Bales Twitter Account  Roxanne Bales News  Roxanne Bales on Facebook



Browse more venture capital transactions:

Prev: 1/14/2015: My Digital Shield venture capital transaction
Next: 1/14/2015: Curemark venture capital transaction


Share this article


News on VC Transactions

We report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary